$0.616
+0.005 (+0.85%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de LAB por análisis de gráficos similares
Alphio's LAB stock price prediction model matches the current Standard BioTools Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.62 (+1.01%). The 1-week path is $0.64 (+4.62%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de Standard BioTools Inc?
Standard BioTools Inc (LAB) appears to be a good buy right now, primarily due to its current price of 0.6099, which is near its 52-week low of 0.59, indicating a potential for recovery. Additionally, the stock has a forward P/E ratio of 0, suggesting that it may be undervalued compared to its earnings potential. The recent merger with Treeline Biosciences is expected to enhance financial stability, providing over $900 million in cash to fund operations into 2029, which is a strong positive catalyst.
LAB cerró en $0.62 el Wednesday, tras subir +0.85%
Standard BioTools Inc (LAB) last closed at $0.616, gaining +0.85%. These facts feed the 1-day and 1-week LAB price prediction above.
Factores de la previsión
Los factores de la previsión de Standard BioTools Inc (LAB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de LAB, ordenadas por similitud.
Análisis de estacionalidad de LAB
Historically the probability of a positive November return for LAB is 4.76%. January offers the highest probability of a positive month at 63.93%, while August is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de LAB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Nov 2026 | $1.46 | $1.72 | $2.08 | +178.55% |
| Dec 2026 | $1.02 | $1.46 | $1.51 | +136.73% |
En 2026, se proyecta que Standard BioTools Inc (LAB) oscile entre $1.02 y $2.08.
Previsión mensual de Standard BioTools Inc para 2026
En Nov de 2026, se proyecta que Standard BioTools Inc promedie $1.72, con un mínimo de $1.46 y un máximo de $2.08.
En Dec de 2026, se proyecta que Standard BioTools Inc promedie $1.46, con un mínimo de $1.02 y un máximo de $1.51.
Artículos relacionados
- How to Rebalance a Concentrated Stock Portfolio in 2026: Mag7 Drift, Tax-Aware Trims, and Practical Rebalance a concentrated stock portfolio in 2026: Mag7 drift risk, 5pp bands, tax-aware trims, RSP/IWM diversifiers, and single-name caps.
- Small Cap Stocks Investing Guide 2026: Russell 2000, Fed Hikes, and the Financing TradeSmall-cap stocks investing guide 2026: Russell 2000 vs S&P, IWM rate sensitivity, floating-rate debt, Fed hikes, valuation discounts, and a practical checklist.
- Santa Claus Rally and the Year-End Stock Market: Investor Guide for Late 2026Santa Claus rally explained: 7-day window stats since 1950, Nov–Dec seasonality, post-midterm 2026 setup, and a risk-managed year-end investing playbook.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.